Medpace Holdings Inc MEDP reported fourth-quarter monetary outcomes after the marketplace close on Monday. Here’s a rundown of the report.
- Q4 Earnings: $ 536.6 million, versus quotes of $534.78 million
- Q4 EPS: $3.67, versus quotes of $2.96
Overall earnings was up 7.7% on a year-over-year basis. Brand-new organization awards amounted to $529.7 million in the quarter, down 13.8% year-over-year. The business ended the duration with a stockpile of roughly $2.9 billion, up 3.2% year-over-year.
Medpace produced $190.7 million in capital from operations throughout the quarter. The business had money and money equivalents of $669.4 million since Dec. 31.
Medpace stated it bought $174.2 countless its typical stock throughout the quarter. The business had $134.6 million staying under its buyback at quarter’s end. In addition, Medpace’s board authorized a boost of $600 million to the business’s buyback program on Feb. 6.
Inspect This Out: Lattice Semiconductor Shares Dive After Mixed Q4 Outcomes, Strong Q1 Assistance
Outlook: Medpace anticipates full-year 2025 earnings to be in the variety of $2.11 billion to $2.21 billion. The business sees full-year profits in the variety of $11.93 per share to $12.69 per share.
Medpace executives will even more talk about the quarter on a call with financiers and experts at 9 a.m. ET Tuesday early morning.
MEDP Cost Action: At publication time Monday, Medpace shares were down 8.33% at $324.97 in after-hours trading, according to Benzinga Pro.
Image: Shutterstock.
Summary Ranking:
Speculative
Market News and Data gave you by Benzinga APIs